171 related articles for article (PubMed ID: 29138980)
1. CD28
Hashimoto H; Sterk M; Schilbach K
Immunol Res; 2018 Feb; 66(1):79-86. PubMed ID: 29138980
[TBL] [Abstract][Full Text] [Related]
2. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
[TBL] [Abstract][Full Text] [Related]
3. Highly focused clonal composition of CD8(+) CD28(neg) T cells in aqueous humor of fuchs heterochromic cyclitis.
Labalette P; Caillau D; Grutzmacher C; Dessaint JP; Labalette M
Exp Eye Res; 2002 Sep; 75(3):317-25. PubMed ID: 12384094
[TBL] [Abstract][Full Text] [Related]
4. T cell receptor (TCR) gene transfer with lentiviral vectors allows efficient redirection of tumor specificity in naive and memory T cells without prior stimulation of endogenous TCR.
Circosta P; Granziero L; Follenzi A; Vigna E; Stella S; Vallario A; Elia AR; Gammaitoni L; Vitaggio K; Orso F; Geuna M; Sangiolo D; Todorovic M; Giachino C; Cignetti A
Hum Gene Ther; 2009 Dec; 20(12):1576-88. PubMed ID: 19678763
[TBL] [Abstract][Full Text] [Related]
5. Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy.
von Holzen U; Adamina M; Bolli M; Weber WP; Zajac P; Groeper C; Reschner A; Feder C; Schumacher R; Marti W; Oertli D; Heberer M; Spagnoli GC
Int J Cancer; 2005 Jun; 115(2):248-55. PubMed ID: 15688403
[TBL] [Abstract][Full Text] [Related]
6. Deep sequencing and flow cytometric characterization of expanded effector memory CD8
Giudice V; Feng X; Lin Z; Hu W; Zhang F; Qiao W; Ibanez MDPF; Rios O; Young NS
Haematologica; 2018 May; 103(5):759-769. PubMed ID: 29419434
[TBL] [Abstract][Full Text] [Related]
7. Novel soluble HLA-A2/MELAN-A complexes selectively stain a differentiation defective subpopulation of CD8+ T cells in patients with melanoma.
Guillaume P; Baumgaertner P; Neff L; Rufer N; Wettstein P; Speiser DE; Luescher IF
Int J Cancer; 2010 Aug; 127(4):910-23. PubMed ID: 19998338
[TBL] [Abstract][Full Text] [Related]
8. Human melanoma immunotherapy using tumor antigen-specific T cells generated in humanized mice.
Hu Z; Xia J; Fan W; Wargo J; Yang YG
Oncotarget; 2016 Feb; 7(6):6448-59. PubMed ID: 26824989
[TBL] [Abstract][Full Text] [Related]
9. Clonal CD8+ T cell expansions in peripheral blood from human immunodeficiency virus type 1-infected children.
McFarland EJ; Harding PA; Striebich CC; MaWhinney S; Kuritzkes DR; Kotzin BL
J Infect Dis; 2002 Aug; 186(4):477-85. PubMed ID: 12195374
[TBL] [Abstract][Full Text] [Related]
10. Peripheral human CD8(+)CD28(+)T lymphocytes give rise to CD28(-)progeny, but IL-4 prevents loss of CD28 expression.
Labalette M; Leteurtre E; Thumerelle C; Grutzmacher C; Tourvieille B; Dessaint JP
Int Immunol; 1999 Aug; 11(8):1327-36. PubMed ID: 10421790
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Melan-A reactive memory CD8+ T cells in a healthy donor.
Voelter V; Rufer N; Reynard S; Greub G; Brookes R; Guillaume P; Grosjean F; Fagerberg T; Michelin O; Rowland-Jones S; Pinilla C; Leyvraz S; Romero P; Appay V
Int Immunol; 2008 Aug; 20(8):1087-96. PubMed ID: 18573812
[TBL] [Abstract][Full Text] [Related]
12. IL-12 controls cytotoxicity of a novel subset of self-antigen-specific human CD28+ cytolytic T cells.
Barbey C; Baumgaertner P; Devevre E; Rubio-Godoy V; Derre L; Bricard G; Guillaume P; Luescher IF; Liénard D; Cerottini JC; Romero P; Rufer N; Speiser DE
J Immunol; 2007 Mar; 178(6):3566-74. PubMed ID: 17339453
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India.
Chandele A; Sewatanon J; Gunisetty S; Singla M; Onlamoon N; Akondy RS; Kissick HT; Nayak K; Reddy ES; Kalam H; Kumar D; Verma A; Panda H; Wang S; Angkasekwinai N; Pattanapanyasat K; Chokephaibulkit K; Medigeshi GR; Lodha R; Kabra S; Ahmed R; Murali-Krishna K
J Virol; 2016 Dec; 90(24):11259-11278. PubMed ID: 27707928
[TBL] [Abstract][Full Text] [Related]
14. Rapid and Continued T-Cell Differentiation into Long-term Effector and Memory Stem Cells in Vaccinated Melanoma Patients.
Gannon PO; Baumgaertner P; Huber A; Iancu EM; Cagnon L; Abed Maillard S; Maby-El Hajjami H; Speiser DE; Rufer N
Clin Cancer Res; 2017 Jul; 23(13):3285-3296. PubMed ID: 27872103
[No Abstract] [Full Text] [Related]
15. Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo.
Jäger E; Ringhoffer M; Karbach J; Arand M; Oesch F; Knuth A
Int J Cancer; 1996 May; 66(4):470-6. PubMed ID: 8635862
[TBL] [Abstract][Full Text] [Related]
16. Peripheral burst of tumor-specific cytotoxic T lymphocytes and infiltration of metastatic lesions by memory CD8+ T cells in melanoma patients receiving interleukin 12.
Mortarini R; Borri A; Tragni G; Bersani I; Vegetti C; Bajetta E; Pilotti S; Cerundolo V; Anichini A
Cancer Res; 2000 Jul; 60(13):3559-68. PubMed ID: 10910069
[TBL] [Abstract][Full Text] [Related]
17. Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8(+)CD57(+)CD28(-) compartment.
Sze DM; Giesajtis G; Brown RD; Raitakari M; Gibson J; Ho J; Baxter AG; Fazekas de St Groth B; Basten A; Joshua DE
Blood; 2001 Nov; 98(9):2817-27. PubMed ID: 11675356
[TBL] [Abstract][Full Text] [Related]
18. Artificial antigen-presenting cells plus IL-15 and IL-21 efficiently induce melanoma-specific cytotoxic CD8+ CD28+ T lymphocyte responses.
Yu X; He J; Mongkhoune S; Peng Y; Xie Y; Su J; Zhou SF; Xie XX; Luo GR; Fang Y; Li X; Li X; Zhou N; Zhao YX; Lu XL
Asian Pac J Trop Med; 2013 Jun; 6(6):467-72. PubMed ID: 23711708
[TBL] [Abstract][Full Text] [Related]
19. CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.
Speiser DE; Valmori D; Rimoldi D; Pittet MJ; Liénard D; Cerundolo V; MacDonald HR; Cerottini JC; Romero P
Eur J Immunol; 1999 Jun; 29(6):1990-9. PubMed ID: 10382762
[TBL] [Abstract][Full Text] [Related]
20. Identification of the T cell clones expanding within both CD8(+)CD28(+) and CD8(+)CD28(-) T cell subsets in recipients of allogeneic hematopoietic cell grafts and its implication in post-transplant skewing of T cell receptor repertoire.
Horiuchi T; Hirokawa M; Kawabata Y; Kitabayashi A; Matsutani T; Yoshioka T; Tsuruta Y; Suzuki R; Miura AB
Bone Marrow Transplant; 2001 Apr; 27(7):731-9. PubMed ID: 11360114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
